Search Results - "PRETOLANI, M"

Refine Results
  1. 1

    Role of HLA‐G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study by Brugière, O., Thabut, G., Krawice‐Radanne, I., Rizzo, R., Dauriat, G., Danel, C., Suberbielle, C., Mal, H., Stern, M., Schilte, C., Pretolani, M., Carosella, E. D., Rouas‐Freiss, N.

    Published in American journal of transplantation (01-02-2015)
    “…Human leukocyte antigen G (HLA‐G) expression is thought to be associated with a tolerance state following solid organ transplantation. In a lung transplant…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Glucocorticoid-induced apoptosis in human eosinophils: Mechanisms of action by DRUILHE, A, LETUVE, S, PRETOLANI, M

    Published in Apoptosis (London) (01-10-2003)
    “…Prominent blood and tissue eosinophilia is clinically manifested in a number of inflammatory states, particularly in allergic diseases. Corticosteroids are the…”
    Get full text
    Journal Article
  5. 5

    Immunohistochemical Study of HLA‐G Expression in Lung Transplant Recipients by Brugière, O, Thabut, G., Pretolani, M., Krawice‐Radanne, I., Dill, C., Herbreteau, A., Poras, I., Moreau, P., Colombat, M., Danel, C., Dehoux, M., Fournier, M., Carosella, E. D., Rouas‐Freiss, N.

    Published in American journal of transplantation (01-06-2009)
    “…Human leukocyte antigen‐G (HLA‐G), a nonclassical HLA class I protein, promotes immune tolerance of solid‐organ allografts, yet its role in lung…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways by PRETOLANI, M, RUFFIE, C, LAPA E SILVA, J.-R, JOSEPH, D, LOBB, R. R, VARGAFTIG, B. B

    Published in The Journal of experimental medicine (01-09-1994)
    “…This report examines the effect of an anti-VLA-4 monoclonal antibody (mAb) HP1/2 on antigen-induced bronchial hyperreactivity to methacholine, and on…”
    Get full text
    Journal Article
  8. 8

    Fas-mediated apoptosis in cultured human eosinophils by DRUILHE, A, CAI, Z, HAILE, S, CHOUAIB, S, PRETOLANI, M

    Published in Blood (01-04-1996)
    “…Previous studies have shown that cytokine-dependent eosinophils undergo apoptosis, yet the mechanisms governing this phenomenon remain obscure. Fas antigen is…”
    Get full text
    Journal Article
  9. 9

    In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs by Lefort, J, Nahori, M A, Ruffie, C, Vargaftig, B B, Pretolani, M

    Published in The Journal of clinical investigation (15-02-1996)
    “…This study examines the effect of purified rabbit antiguinea pig eosinophil-derived major basic protein (MBP) Ig on antigen-induced bronchial hyperreactivity…”
    Get full text
    Journal Article
  10. 10

    Airway Structural Alterations Selectively Associated with Severe Asthma by Benayoun, Laurent, Druilhe, Anne, Dombret, Marie-Christine, Aubier, Michel, Pretolani, Marina

    “…To identify airway pathologic abnormalities selectively associated with severe asthma, we examined 10 control subjects, 10 patients with intermittent asthma,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    (293) Altered Pigr/Iga Mucosal Immunity in Bronchiolitis Obliterans Syndrome by Carlier, F.M., Pretolani, M., Detry, B., Planté-Bordeneuve, T., Longchampt, E., Falque, L., Reynaud-Gobert, M., Hirschi, S., Demant, X., Mornex, J., Tissot, A., Pavec, J. Le, Bunel-Gourdy, V., Foureau, A., Vallée, A., Pilette, C., Brugière, O.

    “…Long-term survival after lung transplantation (LT) is hampered by the occurrence of chronic lung allograft dysfunction (CLAD). CLAD may manifest as…”
    Get full text
    Journal Article
  13. 13

    Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation: Dual Role of FcRγ ITAM by Pasquier, Benoit, Launay, Pierre, Kanamaru, Yutaka, Moura, Ivan C., Pfirsch, Séverine, Ruffié, Claude, Hénin, Dominique, Benhamou, Marc, Pretolani, Marina, Blank, Ulrich, Monteiro, Renato C.

    Published in Immunity (Cambridge, Mass.) (2005)
    “…Serum IgA is considered a discrete housekeeper of the immune system with multiple anti-inflammatory functions, whereas IgA-immune complexes mediate…”
    Get full text
    Journal Article
  14. 14

    Prehospital thrombolysis in rural emergency room and subsequent transport to a coronary care unit: Ravenna myocardial infarction (RaMI) trial by Coccolini, S., Berti, G., Bosi, S., Pretolani, M., Tumiotto, G.

    Published in International journal of cardiology (01-08-1995)
    “…Objective: To assess the feasibility, safety and efficacy of thrombolysis in the Emergency Room of a Rural Hospital with no Coronary Care Unit, and subsequent…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16
  17. 17
  18. 18

    Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus by Lapa e Silva, J R, Ruffié, C, Lefort, J, Nahori, M A, Vargaftig, B B, Pretolani, M

    Published in Mediators of Inflammation (01-01-1999)
    “…WE examined the effect of the immunosuppressive agent, tacrolimus (FK506), on antigen-induced bronchial hyperreactivity to acetylcholine and leukocyte…”
    Get full text
    Journal Article
  19. 19

    Inflammatory events in the blood and airways of guinea pigs immunized to toluene diisocyanate by Mapp, C E, Lapa e Silva, J R, Lucchini, R E, Chitano, P, Rado, V, Saetta, M, Pretolani, M, Karol, M H, Maestrelli, P, Fabbri, L M

    “…Toluene diisocyanate (TDI)-induced asthma is a common cause of occupational lung disease. We used a model to investigate the course of bronchopulmonary…”
    Get more information
    Journal Article
  20. 20

    Effect of active sensitization on the bronchopulmonary responses to tachykinins in the guinea pig. Modulation by peptidase inhibitors by Capaz, F R, Ruffié, C, Lefort, J, Manzini, S, Vargaftig, B B, Pretolani, M

    “…The i.v. administration of substance P (SP, 0.25-16 micrograms/kg) or of the selective metabolic stable NK-1 agonist, [Glp6,Pro9]SP-(6-11) (septide, 0.03-0.25…”
    Get more information
    Journal Article